|
⚲
|
| Zoetis Inc | |
|---|---|
| Ticker | ZTS |
| CIK # | 0001555280 |
| CUSIP | 98978V103 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 235 East 42Nd Street, New York, NY 10017 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2024 |
|---|---|---|
| [0001555280] | 10-K | |
| [0001555280] | 10-Q | |
| [0001555280] | 3 | |
| [0001555280] | 4 | |
| [0001555280] | 8-K | |
| [0001555280] | SC 13D | |
| [0001555280] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Vanguard Group Inc | Zoetis Inc | [2015-02-10] | 5.46 |
| Sachem Head Capital Management LP | Zoetis Inc | [2014-11-12] | 0.9 |
| Pershing Square Capital Management LP | Zoetis Inc | [2014-11-12] | 8.3 |
| Wellington Management Co LLP | Zoetis Inc | [2014-02-14] | 5.86 |
| State Street Corp | Zoetis Inc | [2014-02-05] | 5.0 |
| BlackRock Inc | Zoetis Inc | [2014-01-31] | 6.1 |
| SAC Capital Advisors LP | Zoetis Inc | [2013-06-24] | 7.2 |
| Lazard Asset Management LLC | Zoetis Inc | [2013-03-11] | 8.48 |